Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA requests additional data to support Gilead's NDA for HSV treatment

May 8, 1997

MedImmune reports further clinical results for MEDI-493

May 8, 1997

Pharmacia & Upjohn prepares new antibacterial agents

May 8, 1997

N-Oxide oxazolidinones from Pharmacia & Upjohn

May 7, 1997

Salix to commence clinical trials with Normix

May 6, 1997

Gilead's cidofovir injection approved in the European Union

May 6, 1997

New ganciclovir derivative from Norsk Hydro for HSV infections

May 5, 1997

Clinical results for intravaginal dextrin sulfate gel

May 5, 1997

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Antisense oligonucleotides for RSV infection

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...